Profile of long-acting reversible contraception users in Europe

Eur J Contracept Reprod Health Care. 2009 Jun;14(3):187-95. doi: 10.1080/13625180902741436.


Objectives: To assess the profile of long-acting reversible contraceptives (LARCs) users in Europe.

Methods: A random sample of women aged 15-49 years in 14 European countries (Germany, France, UK, Spain, Italy, Russian Federation, Estonia, Latvia, Lithuania, Austria, Czech Republic, Denmark, Norway, and Sweden) underwent web-based or computer-aided face-to-face interviews in June 2006. In this paper data pertaining to a subgroup of women using LARCs are presented.

Results: A total of 11,490 women participated in the full study. Of these, 1,188 (10%) women were LARC (hormonal implant, injectables, levonorgestrel-releasing intrauterine system [LNG-IUS], copper intrauterine device [Cu-IUD]) users. The age of the LARC users exceeded 30 years for 57-91% of them. Furthermore, more than half of them found convenience an extremely important factor when selecting the LARC as a contraceptive method. As compared to those wearing a Cu-IUD, women using hormonal LARCs experienced fewer physical and emotional symptoms that appeared or worsened during menstruation.

Conclusions: LARCs have their place in the contraceptive market in Europe. The most popular LARCs among European women were the LNG-IUS and the Cu-IUD; both were mainly used by women who had children and had no wish to have more in the future.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Age Distribution
  • Computers
  • Condoms / statistics & numerical data
  • Contraception Behavior / psychology
  • Contraception Behavior / statistics & numerical data*
  • Contraceptive Agents, Female / therapeutic use*
  • Contraceptive Devices / statistics & numerical data*
  • Contraceptive Devices, Female / statistics & numerical data
  • Drug Implants / therapeutic use
  • Europe
  • Female
  • Humans
  • Interviews as Topic
  • Intrauterine Devices, Copper / statistics & numerical data
  • Levonorgestrel / therapeutic use
  • Middle Aged
  • Patient Satisfaction
  • Young Adult


  • Contraceptive Agents, Female
  • Drug Implants
  • Levonorgestrel